ethinyl estradiol has been researched along with mifepristone in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 7 (24.14) | 18.2507 |
2000's | 12 (41.38) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dansette, PM; Fontana, E; Poli, SM | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hollenberg, PF; Johnson, WW; Lin, HL; Medower, C; Zhang, H | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Elstein, M; Russell, J; Webb, AM | 1 |
Baird, DT; Dewar, M; Glasier, A; Mackie, M; Thong, KJ | 1 |
Haspels, AA | 3 |
Derman, SG; Peralta, LM | 1 |
von Hertzen, H | 1 |
Wertheimer, RE | 1 |
Croxatto, HB; Devoto, L; Durand, M; Ezcurra, E; Larrea, F; Nagle, C; Ortiz, ME; Vantman, D; Vega, M; von Hertzen, H | 1 |
Glasier, A | 1 |
Ashok, PW; Flett, GM; Melvin, L; Stalder, C; Templeton, A; Wagaarachchi, PT | 1 |
Lo, SS | 1 |
Haehner, T; Müller-Enoch, D; Refaie, MO | 1 |
Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 1 |
Findlay, JK; Fraser, IS; Hickey, M; O'Connor, V; Palmer, D; Salamonsen, LA; Weisberg, E | 2 |
Amaliev, G | 1 |
Barbier, M; Dréan, Y; Lalou, Y; Lanta, S; Mention, JE | 1 |
Bernstein, DI; Bernstein, IL; Bernstein, JA; Lummus, ZL | 1 |
Burger, HG; Croxatto, HB; Findlay, JK; Fraser, IS; Weisberg, E | 1 |
Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
Badmus, OO; Olatunji, LA | 1 |
7 review(s) available for ethinyl estradiol and mifepristone
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Postcoital contraception: present and future options.
Topics: Adolescent; Adolescent Behavior; Adult; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Forecasting; Humans; Mifepristone; Sexual Behavior | 1995 |
Emergency contraception: a review.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Emergencies; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone | 1994 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
Emergency postcoital contraception.
Topics: Abortifacient Agents; Adolescent; Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Decision Making; Drug Administration Schedule; Drug Therapy, Combination; Emergency Treatment; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation-Inducing Agents; Mifepristone; Time Factors | 2000 |
Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
Topics: Animals; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Pregnancy; Progestins | 2001 |
Emergency contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Risk Factors; Therapeutic Equivalency | 2002 |
7 trial(s) available for ethinyl estradiol and mifepristone
Article | Year |
---|---|
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Middle Aged; Mifepristone; Nausea; Pregnancy; Treatment Outcome; Vomiting | 1992 |
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Hormonal; Emergencies; Ethinyl Estradiol; Female; Humans; Menstruation; Middle Aged; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Pregnanediol; Progesterone; Random Allocation | 1992 |
A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Ovulation; Patient Satisfaction; Pregnancy; Treatment Outcome | 2002 |
Mifepristone versus the Yuzpe regimen (PC4) for emergency contraception.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Patient Satisfaction; Surveys and Questionnaires; Treatment Outcome | 2004 |
A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Middle Aged; Mifepristone; Placebos | 2006 |
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Mifepristone; Uterine Hemorrhage | 2009 |
A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Drug Implants; Drug Interactions; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinization; Menstrual Cycle; Middle Aged; Mifepristone; Ovary; Ovulation Inhibition; Ultrasonography; Uterine Hemorrhage; Viscosity; Young Adult | 2011 |
15 other study(ies) available for ethinyl estradiol and mifepristone
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
Topics: Antineoplastic Agents; Binding Sites; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochromes b5; Dose-Response Relationship, Drug; Escherichia coli; Humans; Molecular Structure; Oxidation-Reduction; Protein Binding; Quinolines; Thiophenes | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Postcoital contraception.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Contraceptives, Postcoital; Cyclophosphamide; Epirubicin; Ethinyl Estradiol; Female; Humans; Mifepristone; Pregnancy | 1991 |
Morning-after pill creates controversy.
Topics: Abortifacient Agents; Abortion, Induced; Contraceptives, Postcoital, Hormonal; Embryo Implantation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Mifepristone; Norgestrel; Pregnancy; United States | 1990 |
Post-coital contraception.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Developed Countries; Endocrine System; Endometrium; Ethinyl Estradiol; Europe; Family Planning Services; Hormone Antagonists; Hormones; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Netherlands; Physiology; Progesterone; Progestins; Uterus | 1988 |
Current perspectives on emergency contraception.
Topics: Contraception Behavior; Contraceptives, Postcoital; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hong Kong; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone; Nonprescription Drugs; Patient Education as Topic; Pregnancy; Pregnancy, Unwanted; Self Administration | 2002 |
Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system.
Topics: Antifungal Agents; Antimalarials; Catalysis; Chromatography, High Pressure Liquid; Cimetidine; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Estrogen Antagonists; Ethinyl Estradiol; Flavanones; Hormone Antagonists; Humans; Immunosuppressive Agents; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Mifepristone; NADPH-Ferrihemoprotein Reductase; Phospholipids; Quinidine; Quinine; Tacrolimus | 2004 |
[Emergency contraception ].
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Mifepristone; Norgestrel; Time Factors | 2008 |
[Early home abortion and immediate contraception with Evra® patch].
Topics: Abortion, Induced; Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Mifepristone; Norgestrel; Pregnancy; Transdermal Patch; Young Adult | 2011 |
A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis.
Topics: Anaphylaxis; Angioedema; Animals; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dermatitis; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Estrogens; Ethinyl Estradiol; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Mice; Middle Aged; Mifepristone; Nafarelin; Norethindrone; Progesterone; Urticaria | 2011 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |